World Markets Generics and Biosimilars

With coverage of more than 60 pharmaceutical markets and every single generic drug approved since 2003 in the top five E.U. countries and the United States, our service provides crucial insight and analysis to those who manufacture, regulate, or invest in generics.  

World Markets Generics and Biosimilars is a suite of services providing comprehensive information on the global generics industry. Subscribers receive:

• Same-Day Analysis of more than 60 markets 
• Special Reports at the corporate, therapeutic area, regional and global levels 
• Country Reports offering in-depth generics analysis for 21 markets 
• Company Profiles of the top players 
• Litigation Highlights Database on patent litigation affecting the top 50 products 
• Biosimilars Market Watch for regulation and market opportunities

Benefits:

World Markets Generics and Biosimilars enables you to:

• Anticipate opportunities and challenges in the generics and biosimilars markets 
• Monitor competitors and customers 
• Make informed decisions 
• Assess the impact of a changing regulatory environment 
• Plan and forecast budgets 
• Stay up to date with recent industry developments and market trends 
• Understand legal challenges for product patents

Same-Day Generics Analysis

• Daily desktop delivery 
• Timely, ongoing analysis of regional, national, and global developments affecting the generics industry 
• Coverage of more than 60 pharmaceutical markets 
• Major topics, including: 
  • Financial results of leading industry players 
  • Merger and acquisition (M&A) activity 
  • Marketing/R&D partnerships 
  • Generic drug filings and approvals
  • Pipeline developments 
  • Drug launch and pricing announcements 
  • Patent challenges and disputes 
  • Regulatory changes affecting the generic sector 
  • Pricing and reimbursement policy revisions 
  • Generic market size and growth trends 
  • Efforts to promote the use of generics 
  • The evolution of generics and biosimilars approval regulations 
    

Special Reports 

• Monthly in-depth analysis on topics affecting generics and biosimilars at the regional, global, therapeutic group, and corporate level 
  

Country Reports 

• Structured analysis of the generics sector in 21 markets, including BRIC and fast-growing CEE markets 
• In-depth analysis of generics: 
  • Pricing and reimbursement regulation 
  • Competitive challenges 
  • Barriers to market entry 
  • Informal arrangements affecting pricing and launch strategies in each market 
    

Company Profiles 

• Coverage of top generics industry players 
• Overview of company operations and strategy 
• Product portfolio and pipeline development 
• Financial performance 
• M&A activity
  

Litigation Highlights Database 

• Monitoring and analysis of U.S. patent litigation affecting the top-50 pharmaceutical products 
  

Biosimilars Market Watch 

• Country reports providing an in-depth review of regulatory changes related to abbreviated approval of biosimilars 
• Databases tracking biosimilars market opportunities and companies involved in biosimilars development

Our expert team provides an independent, fact-based view of the healthcare and pharmaceutical industry, fully supported by our 325+ economists and analysts worldwide with expertise in over 120 industries and 200 countries.

IHS Global Insight is the world leader in economic and financial analysis, forecasting, and market intelligence—with more than 40 years experience and an outstanding record for accuracy.